Skip to main content

Want a detailed portfolio tracker?

BioNTech (BNTX) P/E (2019 - 2026)

BioNTech (BNTX) P/E from Oct 10, 2019 to Jul 21, 2026. The TTM BioNTech (BNTX) P/E is -15.53. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of BioNTech (BNTX)

YearP/EChange
2026-15.53-12.77%
2025-17.81-52.55%
2024-37.53-524.37%
20238.84+154.39%
20223.48-37.87%
20215.60-99.19%
2020691.66-1883.90%
2019-38.77N/A

Comparison BioNTech (BNTX) P/E with competitors

BioNTech (BNTX) P/E is -15.53.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.03%
ENLVEnlivex Ltd0.07-100.48%
FGENFibroGen Inc0.24-101.55%
CHRSCoherus Biosciences Inc0.85-105.46%
FBIOFortress Biotech Inc0.95-106.11%
ORMPOramed Pharmaceuticals Inc1.50-109.68%
AGENAgenus Inc3.01-119.37%
INVAInnoviva Inc3.15-120.30%
VXRTVaxart Inc3.55-122.85%
CRMDCorMedix Inc3.63-123.36%
CVACCureVac N.V.4.45-128.62%
GLPGGalapagos NV4.86-131.28%
SRPTSarepta Therapeutics Inc4.88-131.43%
ABEOAbeona Therapeutics Inc5.39-134.68%
ABUSArbutus Biopharma Corp5.60-136.02%
ZVRAZevra Therapeutics Inc5.89-137.90%
SPROSpero Therapeutics Inc6.23-140.09%
CGENCompugen Ltd6.31-140.64%
RIGLRigel Pharmaceuticals6.87-144.24%
SLXNSilexion Therapeutics Corp7.30-146.97%
OMEROmeros Corporation9.26-159.60%
AUPHAurinia Pharmaceuticals Inc9.58-161.70%
PLXProtalix BioTherapeutics Inc10.89-170.11%
ACADAcadia Pharmaceuticals Inc11.73-175.50%
TBPHTheravance Biopharma Inc12.26-178.94%
ADMAAdma Biologics Inc12.42-179.94%
HRMYHarmony Biosciences Holdings Inc13.82-188.96%
SABSSAB Biotherapeutics Inc14.14-191.00%
NAGENiagen Bioscience Inc14.82-195.39%
INCYIncyte Corp15.82-201.85%
REGNRegeneron Pharmaceuticals Inc15.86-202.07%
PBYIPuma Biotechnology Inc17.32-211.47%
CPRXCatalyst Pharmaceuticals Inc17.44-212.26%
EXELExelixis Inc17.54-212.90%
TGTXTG Therapeutics Inc18.97-222.09%
MDXGMimedx Group Inc20.55-232.30%
XOMAXOMA Royalty Corp22.87-247.26%
ARGXArgen X SE24.30-256.42%
CTMXCytomX Therapeutics Inc24.82-259.79%
XOMAOXOMA Royalty Corp25.34-263.16%
HALOHalozyme Therapeutics Inc25.62-264.95%
XOMAPXOMA Royalty Corp25.67-265.25%
VRTXVertex Pharmaceuticals Inc27.99-280.22%
RPRXRoyalty Pharma plc - Class A28.69-284.68%
SLNOSoleno Therapeutics Inc29.02-286.79%
ASNDAscendis Pharma A/S30.09-293.68%
LGNDLigand Pharmaceuticals Inc - Class B37.91-344.06%
APLSApellis Pharmaceuticals Inc39.02-351.20%
KRYSKrystal Biotech Inc45.34-391.90%
ONCBeiGene Ltd69.54-547.67%
PHARPharming Group N.V.75.03-582.98%
TECHBio-Techne Corp101.96-756.36%
VCELVericel Corp109.92-807.62%
ALNYAlnylam Pharmaceuticals Inc117.96-859.40%
GMABGenmab140.29-1003.12%
TLXTelix Pharmaceuticals Ltd162.15-1143.86%
CORTCorcept Therapeutics Inc212.86-1470.27%